What Ubie does

Ubie, Inc. is a Tokyo-headquartered (with inferred US incorporation) digital health company founded in May 2017 by CEO Yoshinori Abe that operates an AI-powered symptom checker and related consumer health services across Japan, the United States, and other international markets. Its core product is a free, 3-minute AI-driven questionnaire that processes user-reported symptoms, demographics, and medical history to generate personalized reports on possible causes, treatment information, and guidance on when to seek medical care.

The platform is grounded in 50,000+ clinical data sources drawn from published scientific papers and is supervised by 50+ board-certified medical experts worldwide across specialties including emergency medicine, neurology, psychiatry, obstetrics and gynecology, cardiology, and internal medicine, drawn from institutions such as the Icahn School of Medicine at Mount Sinai, Penn State Health, and the U.S. Department of Veterans Affairs. An independent medrxiv comparative study reported a 71.6% top-10 hit accuracy for Ubie's symptom checker, outperforming competitor symptom checkers averaging approximately 60%. Supporting product lines include a doctor-authored Q&A database ("Doctor's Note"), targeted condition assessments ("Checkup"), and an AI-assisted support service ("Smart Support").

Ubie runs a product-led, freemium go-to-market with self-serve consumer access via ubiehealth.com, a Google Play mobile app, and Japan-specific domain ubie.app, requiring no credit card or account signup. The company extends into B2B through partnerships with over 900 medical institutions worldwide that both use and continuously train the AI system in real-world clinical practice. Specific pricing for premium or institutional tiers, revenue figures, funding rounds, and headcount are not publicly disclosed; the company is private with no parent entity or subsidiaries disclosed, and has no public listing.

Name

Ubie

Legal name

Ubie, Inc.

Website

https://ubiehealth.com

Company type

Private

Founded year

2017

Operating status

Operating

Short description

Ubie operates a free, AI-powered symptom checker that generates personalized reports on possible causes and care guidance for consumers, backed by 50,000+ clinical data sources and supervised by 50+ medical experts, with B2B partnerships across 900+ medical institutions in Japan, the US, and other markets.

Ownership category

akta.pro rank

Product category

Digital Health / AI Symptom Assessment

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)

Keywords

• AI symptom checker
• Digital health platform
• Clinical decision support
• Patient symptom assessment
• Healthcare navigation software

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Freemium Symptom Checker: The core symptom checker is provided free to consumers. The company likely monetizes through premium services, partnerships with healthcare institutions, or B2B licensing of their medical AI technology. The exact revenue model details are not publicly disclosed.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Ubie provides a free AI-powered symptom checker that delivers personalized 3-minute assessments of possible causes based on user-reported symptoms, demographics, and medical history. The service is supervised by 50+ medical specialists and supported by 50,000+ clinical data sources, with additional offerings including Doctor's Note (physician-authored medical Q&A), Checkup (condition-specific assessments such as asthma), and Smart Support (AI-assisted health guidance).

Product overview

Ubie is a healthcare AI company offering a suite of digital health services centered around its AI-powered symptom checker. The core product is the Symptom Checker, which uses artificial intelligence to analyze user-reported symptoms and generate personalized health reports. Supporting products include Doctor's Note (a database of doctor-written medical explanations), Checkup (targeted health assessments for specific conditions like asthma), and Smart Support (additional AI-powered guidance services). The platform is designed to help users understand their symptoms, identify possible causes, and determine when to seek professional medical care.

Differentiator

Problem solved

Functional benefit

Brands

• Symptom Checker: AI-powered symptom assessment tool that generates personalized reports on possible causes in approximately 3 minutes.
• Doctor's Note
• Checkup
• Smart Support

Products and services

• Symptom Checker

Quantifiable outcome

• 71.6% Top-10 hit accuracy demonstrated in independent medrxiv study, surpassing leading symptom checkers averaging ~60% accuracy

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Medical Institutions WorldwidecoreOthersOver 900 medical institutions around the world trust Ubie's AI and continuously train the system through their clinical practice. This partnership provides Ubie with real-world clinical data and validation while offering institutions an AI-powered symptom assessment tool.
• Supervising Medical ExpertscoreOthers50+ medical experts worldwide, including board-certified specialists from institutions such as Icahn School of Medicine at Mount Sinai, Penn State Health, U.S. Department of Veterans Affairs, and other healthcare organizations, supervise and validate Ubie's medical content and AI.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Ada Health: Ada Health offers an AI-powered symptom assessment app for consumers and B2B healthcare partners, closely matching Ubie's product, target users, and B2B clinical decision support model.
• Buoy Health: Buoy Health provides an AI-driven symptom checker that triages users to appropriate care and partners with health plans and providers, directly overlapping Ubie's consumer-triage + B2B-institution model.
• Infermedica: Infermedica builds AI symptom-checking and triage APIs sold to insurers, providers, and telemedicine companies, paralleling Ubie's algorithmic triage and healthcare-institution channel.
• Mediktor: Mediktor offers an AI symptom-checker and triage engine sold to hospitals, insurers, and telehealth platforms, mirroring Ubie's clinical decision support positioning and B2B go-to-market.
• Babylon Health (eMed): Babylon pioneered AI symptom triage and virtual care for consumers and provider systems; while its consumer app has wound down, its symptom-assessment technology and enterprise deployments remain comparable to Ubie's product surface.
• K Health: K Health combines AI-driven symptom/triage with text-based primary care visits, overlapping Ubie's consumer symptom-check foundation and the care-navigation outcome Ubie recommends.

Broad incumbents

• Mayo Clinic (Symptom Checker): Mayo Clinic offers a clinician-authored symptom checker as part of a much broader consumer health information and care-delivery portfolio, providing a credible incumbent alternative for users comparing symptom tools.
• WebMD: WebMD operates a leading consumer health information site with a built-in symptom checker, serving the same top-of-funnel consumer need as Ubie but inside a broader advertising-supported media business.
• Healthline: Healthline publishes symptom and condition content at large scale and competes for Ubie's same consumer symptom-research audience, though without a comparable AI triage product.

Emerging players

• Docus: Docus offers AI-augmented health consultations and symptom analysis, addressing a similar consumer pre-visit use case to Ubie but with a narrower product surface and earlier-stage traction.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ubie-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ubie